Linked bibliography for the SEP article "The Human Genome Project" by Lisa Gannett

This is an automatically generated and experimental page

If everything goes well, this page should display the bibliography of the aforementioned article as it appears in the Stanford Encyclopedia of Philosophy, but with links added to PhilPapers records and Google Scholar for your convenience. Some bibliographies are not going to be represented correctly or fully up to date. In general, bibliographies of recent works are going to be much better linked than bibliographies of primary literature and older works. Entries with PhilPapers records have links on their titles. A green link indicates that the item is available online at least partially.

This experiment has been authorized by the editors of the Stanford Encyclopedia of Philosophy. The original article and bibliography can be found here.

  • Adams, Mark D., et al., 1991, “Complementary DNA Sequencing: Expressed Sequence Tags and Human Genome Project,” Science 252 (21 Jun): 1651–1656. (Scholar)
  • Adams, Mark D., et al., 1992, “Sequence Identification of 2,375 Human Brain Genes,” Nature 355 (13 Feb): 632–634. (Scholar)
  • Adams, Mark D., et al., 2000, “The Genome Sequence of Drosophila melanogaster,” Science 287 (24 Mar): 2185–2195. (Scholar)
  • Agar, Nicolas, 1995, “Designing Babies: Morally Permissible Ways to Modify the Human Genome,” Bioethics 9: 1–15. (Scholar)
  • Alberts, Bruce and Aaron Klug, 2000, “The Human Genome Itself Must Be Freely Available to All Humankind,” Nature 404 (23 Mar): 325. (Scholar)
  • Allen, Anita L., 1997, “Genetic Privacy: Emerging Concepts and Values,” in Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era, edited by Mark A. Rothstein, 31–59, New Haven and London: Yale University Press. (Scholar)
  • Allen, Garland E., 1975, “The Introduction of Drosophila into the Study of Heredity and Evolution: 1900–1910,” Isis 66: 322–333. (Scholar)
  • Allen, Garland E. 1994. “The Genetic Fix: The Social Origins of Genetic Determinism.” In Challenging Racism and Sexism: Alternatives to Genetic Explanations, edited by Ethel Tobach and Betty Rosoff, 163–187, New York: The Feminist Press at CUNY. (Scholar)
  • Allhoff, Fritz, 2005, “Germ-Line Genetic Enhancement and Rawlsian Primary Goods,” Kennedy Institute of Ethics Journal 15(1): 39–56. (Scholar)
  • American Society of Human Genetics Board of Directors, 1990, “The American Society of Human Genetics Statement on Cystic Fibrosis Screening,” American Journal of Human Genetics 46: 393 [Available online]. (Scholar)
  • American Society of Human Genetics Board of Directors, 1992, “Statement of the American Society of Human Genetics on Cystic Fibrosis Carrier Screening,” American Journal of Human Genetics 51: 1443–1444 [Available online]. (Scholar)
  • Anderson, French W., 1990, “Genetics and Human Malleability,” Hastings Center Report 20(1): 21–24. (Scholar)
  • Andrews, Lori B., 1994, “Public Choices and Private Choices: Legal Regulation of Genetic Testing,” in Justice and the Human Genome Project, edited by Timothy Murphy and Marc A. Lappé, 46–74, Berkeley: University of California Press. (Scholar)
  • Andrews, Lori B., 1997, “Gen-Etiquette: Genetic Information, Family Relationships, and Adoption,” in Genetic Secrets, 255–280. (Scholar)
  • Andrews, Lori B., Fullarton, Jane E., Holtzman, Neil A., and Arno G. Motulsky, eds., 1994, Assessing Genetic Risks: Implications for Health and Social Policy, Washington, D.C.: National Academy Press. (Scholar)
  • Ankeny, Rachel A., 2000, “Fashioning Descriptive Models in Biology: Of Worms and Wiring Diagrams,” Philosophy of Science 67 (Proceedings): S260-S272. (Scholar)
  • Ankeny, Rachel A., 2001, “Model Organisms as Models: Understanding the ‘Lingua Franca’ of the Human Genome Project,” Philosophy of Science 68 (Proceedings): S251-S261. (Scholar)
  • Ankeny, Rachel A., 2003, “A View of Bioethics from Down Under,” Cambridge Quarterly of Healthcare Ethics 12: 242–246. (Scholar)
  • Annas, George J., 1990, “Mapping the Human Genome and the Meaning of Monster Mythology,” Emory Law Journal 39: 629–664. (Scholar)
  • Annas, George J., 1993, “Privacy Rules for DNA Data Banks: Protecting Coded ‘Future Diaries,’” Journal of the American Medical Association 270: 2346–2350. (Scholar)
  • Annas, George J., 1994, “Rules for Gene Banks: Protecting Privacy in the Genetics Age,” in Justice and the Human Genome Project, 75–90. (Scholar)
  • Annas, George J., Leonard H. Glantz, and Patricia A. Roche, 1995, “Drafting the Genetic Privacy Act: Science, Policy, and Practical Considerations,” Journal of Law, Medicine & Ethics 23: 360–366. (Scholar)
  • Anonymous, 2000, “Human Genome Projects: Work in Progress,” Nature 405 (29 June): 981. (Scholar)
  • Anonymous, 2003, “International Consortium Completes Human Genome Project,” Genomics & Genetics Weekly (9 May): 32. (Scholar)
  • Baron, Marcia, 2001, “Crimes, Genes, and Responsibility,” in Genetics and Criminal Behavior, edited by David Wasserman and Robert Wachbroit, 201–223, Cambridge: Cambridge University Press. (Scholar)
  • Baylis, Françoise and Jason Scott Robert, 2004, “The Inevitability of Genetic Enhancement Technologies,” Bioethics 18: 1–27. (Scholar)
  • Baylis, Françoise and Jason Scott Robert, 2006, “Radical Rupture: Exploring Biological Sequelae of Volitional Inheritable Genetic Modification,” in The Ethics of Inheritable Genetic Modification: A Dividing Line? edited by John E.J. Rasko, Gabrielle M. O'sullivan, and Rachel A. Ankeny, 131–148, Cambridge: Cambridge University Press. (Scholar)
  • Beckman, Ludvig, 2004, “Are Genetic Self-Tests Dangerous? Assessing the Commercialization of Genetic Testing in Terms of Personal Autonomy,” Theoretical Medicine 25: 387–398. (Scholar)
  • Beckwith, Jon and Joseph S. Alper, 1998, “Reconsidering Genetic Antidiscrimination Legislation,” Journal of Law, Medicine & Ethics 26: 205–210. (Scholar)
  • Bennett, Rebecca, 2001, “Antenatal Genetic Testing and the Right to Remain in Ignorance,” Theoretical Medicine 22: 461–471. (Scholar)
  • Bereano, Philip L., 1992, “The Impact of DNA-based Identification Systems on Civil Liberties,” DNA on Trial: Genetic Identification and Criminal Justice, edited by Paul R. Billings, 119–128, Cold Spring Harbor Laboratory Press. (Scholar)
  • Biesecker, Barbara Bowles, 1997, “Privacy in Genetic Counseling,” in Genetic Secrets, 108–125. (Scholar)
  • Billings, Paul R., Mel A. Kohn, Margaret de Cuevas, Jonathan Beckwith, Joseph S. Alper, and Marvin R. Natowicz, 1992, “Discrimination as a Consequence of Genetic Testing,” American Journal of Human Genetics 50: 476–482. (Scholar)
  • Blattner, Frederick R. et al., 1997, “The Complete Genome Sequence of Escherichia coli K-12,” Science 277 (5 Sep): 1453–1462. (Scholar)
  • Bodmer, Walter and Robin McKie, 1994, The Book of Man: The Quest to Discover Our Genetic Heritage, Toronto: Viking Press. (Scholar)
  • Bostrom, Nick, 2003, “Human Genetic Enhancements: A Transhumanist Perspective,” Journal of Value Inquiry 37: 493–506. (Scholar)
  • Boylan, Michael, 2002, “Genetic Testing,” Cambridge Quarterly of Healthcare Ethics 11: 246–256. (Scholar)
  • Branca, Malorye A., 2005, “Gene Therapy: Cursed or Inching Towards Credibility?” Nature Biotechnology 23: 519–521. (Scholar)
  • Brock, Dan, 1995, “The Non-Identity Problem and Genetic Harms—The Case of Wrongful Handicaps,” Bioethics 9: 269–275. (Scholar)
  • Brody, Baruch A., 2002, “Freedom and Responsibility in Genetic Testing,” Social Philosophy and Policy Foundation 343–359. (Scholar)
  • Brown, Jonathan S., 2001, “Genetic Manipulation in Humans as a Matter of Rawlsian Justice,” Social Theory and Practice 27: 83–110. (Scholar)
  • Buchanan, Allen, Dan W. Brock, Normal Daniels, and Daniel Wikler, 2000, From Chance to Choice: Genetics and Justice, Cambridge: Cambridge University Press. (Scholar)
  • Burian, Richard M., 1993, “How the Choice of Experimental Organism Matters: Epistemological Reflections on an Aspect of Biological Practice,” Journal of the History of Biology 26: 351–367. (Scholar)
  • Burke, David T., Carle, Georges F., and Maynard V. Olson, 1987, “Cloning of Large Segments of Exogenous DNA into Yeast by Means of Artificial Chromosome Vectors,” Science 236 (15 May): 806–812. (Scholar)
  • The C. elegans Sequencing Consortium, 1998, “Genome Sequence of the Nematode C. elegans: A Platform for Investigating Biology,” Science 282 (11 Dec): 2012–2018. (Scholar)
  • Callahan, Daniel, 1998, “Cloning: Then and Now,” Cambridge Quarterly of Healthcare Ethics 7: 141–144. (Scholar)
  • Chumakov, I.M., et al., 1995, “A YAC Contig Map of the Human Genome,” Nature 377: S175-S298. (Scholar)
  • Clayton, Ellen Wright, 1997a, “Informed Consent and Genetic Research,” in Genetic Secrets, 126–136. (Scholar)
  • Clayton, Ellen Wright, 1997b, “Genetic Testing in Children,” Journal of Medicine and Philosophy 22: 233–251. (Scholar)
  • Cohen, Cynthia B., 1998, “Wrestling with the Future: Should We Test Children for Adult-Onset Genetic Conditions,” Kennedy Institute of Ethics Journal 8: 111–130. (Scholar)
  • Collins, Francis and David Galas, 1993, “A New Five-Year Plan for the U.S. Human Genome Project,” Science 262 (1 Oct): 43–46. (Scholar)
  • Collins, Francis S., Ari Patrinos, Elke Jordan, Aravinda Chakravarti, Raymond Gesteland, LeRoy Walters, and the members of the DOE and NIH planning groups, 1998, “New Goals for the U.S. Human Genome Project: 1998–2003,” Science 282 (23 Oct): 682–689. (Scholar)
  • Collins, Francis S., Eric D. Green, Alan E. Guttmacher, and Mark S. Guyer. 2003. “A Vision for the Future of Genomics Research: A Blueprint for the Genomic Era,” Nature 422 (24 April): 1–13. (Scholar)
  • Cook-Deegan, Robert, 1994, The Gene Wars: Science, Politics, and the Human Genome, New York: W. W. Norton. (Scholar)
  • Cooper, Necia Grant, 1994, The Human Genome Project: Deciphering the Blueprint of Heredity, Mill Valley, CA: University Science Books. (Scholar)
  • Cranor, Carl F., 1994, “Genetic Causation,” in Are Genes Us? The Social Consequences of the New Genetics, edited by Carl F. Cranor, 125–141, New Brunswick, NJ: Rutgers University Press. (Scholar)
  • Daniels, Norman, 1994, “The Genome Project, Individual Differences, and Just Health Care,” in Justice and the Human Genome Project, pp. 110–132. (Scholar)
  • Daniels, Norman, 2004, “The Functions of Insurance and the Fairness of Genetic Underwriting,” in Genetics and Life Insurance: Medical Underwriting and Social Policy, edited by Mark A. Rothstein, 119–145, Cambridge and London: MIT Press. (Scholar)
  • Darnovsky, Marcy, 2001, “The Case against Designer Babies: The Politics of Genetic Enhancement,” in Redesigning Life? The Worldwide Challenge to Genetic Engineering, edited by Brian Tokar, 133–149, London and New York: Zed Books. (Scholar)
  • Davies, Kevin, 2001, Cracking the Genome: Inside the Race to Unlock Human DNA, Baltimore and London: Johns Hopkins University Press. (Scholar)
  • Davis, Bernard D. and Colleagues, 1990, “The Human Genome and Other Initiatives,” Science 249 (27 July): 342–343. (Scholar)
  • Davis, Dena S., 2000, “Groups, Communities, and Contested Identities in Genetic Research,” Hasting Center Report 30 (6): 38–45. (Scholar)
  • Davis, Dena S., 2001, Genetic Dilemmas: Reproductive Technology, Parental Choices, and Children's Futures, New York: Routledge. (Scholar)
  • Davis, Rowland H., 2003, The Microbial Models of Molecular Biology: From Genes to Genomes, Oxford: Oxford University Press. (Scholar)
  • Davis, Rowland H., 2004, “The Age of Model Organisms,” Nature Reviews/Genetics 5: 69–77. (Scholar)
  • de Chadarevian, Soraya, 2002, Designs for Life: Molecular Biology after World War II, Cambridge: Cambridge University Press. (Scholar)
  • Deloukas, P., et al., 1998, “A Physical Map of 30,000 Human Genes,” Science 282 (23 Oct): 744–746. (Scholar)
  • de Melo-Martín, Immaculada, 2005, Taking Biology Seriously: What Biology Can and Cannot Tell Us About Moral and Public Policy Issues, Lanham, MD: Rowman & Littlefield. (Scholar)
  • Department of Trade and Industry (U.K.), 2003, “Heads of Government Congratulate Scientists on Completion of Human Genome Project,” Hermes Database (12 April); LexisNexis Academic. (Scholar)
  • Dib, Colette et al., 1996, “A Comprehensive Genetic Map of the Human Genome Based on 5,264 Microsatellites,” Nature 380 (14 Mar): 152–154. (Scholar)
  • Dickenson, Donna, 2004, “Consent, Commodification and Benefit-Sharing in Genetic Research,” Developing World Bioethics 4: 109–124. (Scholar)
  • Dickson, David, 1998, “British Funding Boost is Wellcome News,” Nature 393 (21 May): 201. (Scholar)
  • Dickson, David, 2000, “NIH Opposes Plans for Patenting ‘Similar’ Gene Sequences,” Nature 405 (4 May): 3. (Scholar)
  • Dietrich, William F. et al., 1996, “A Comprehensive Genetic Map of the Mouse Genome,” Nature 380 (14 Mar): 149–152. (Scholar)
  • Dizikes, Peter, 2007, “Gene Information Opens New Frontier in Privacy Debate,” Boston Globe (24 Sep). (Scholar)
  • Draper, Elaine, 1991, Risky Business: Genetic Testing and Exclusionary Practices in the Hazardous Workplace, Cambridge: Cambridge University Press. (Scholar)
  • Dresser, Rebecca, 2004, “Designing Babies: Human Research Issues,” IRB: Ethics & Research 26(5): 1–8. (Scholar)
  • Dulbecco, Rene, 1986, “A Turning Point in Cancer Research: Sequencing the Human Genome,” Science 231 (7 Mar): 1055–1056. (Scholar)
  • Dunham, I. et al., 1999, “The DNA Sequence of Human Chromosome 22,” Nature 402 (2 Dec): 489–495. (Scholar)
  • Dupré, John, 2004, “Understanding Contemporary Genomics,” Perspectives on Science, 12: 320–338. (Scholar)
  • Duster, Troy, 1990, Backdoor to Eugenics, New York: Routledge. (Scholar)
  • Eisenberg, Rebecca, 2002, “How Can You Patent Genes?American Journal of Bioethics 2(3): 3–11. (Scholar)
  • Ellis, Justine A. and Rodney D. Sinclair, 2008, “Male Pattern Baldness: Current Treatment, Future Prospects,” Drug Discovery Today; in press. (Scholar)
  • Ereshefsky, Marc, 1992, The Units of Evolution: Essays on the Nature of Species, Cambridge, MA: MIT Press. (Scholar)
  • Farrelly, Colin, 2002, “Genes and Social Justice: A Rawlsian Reply to Moore,” Bioethics 16: 72–83. (Scholar)
  • Fleck, Leonard M., 1994, “Just Genetics: A Problem Agenda,” in Justice and the Human Genome Project, 133–152. (Scholar)
  • Fleischmann, Robert D. et al., 1995, “Whole-Genome Random Sequencing and Assembly of Haemophilus influenzae Rd,” Science 269 (28 Jul): 496–512. (Scholar)
  • Flory, James H. and Philip Kitcher, 2004, “Global Health and the Scientific Research Agenda,” Philosophy & Public Affairs 32: 36–65. (Scholar)
  • Fukuyama, Francis, 2002, Our Posthuman Future: Consequences of the Biotechnology Revolution, New York: Picador. (Scholar)
  • Gannett, Lisa, 1997, “Tractable Genes, Entrenched Social Structures,” Biology and Philosophy 12: 403–419. (Scholar)
  • Gannett, Lisa, 1999, “What's in a Cause? The Pragmatic Dimensions of Genetic Explanations,” Biology and Philosophy 14: 349–374. (Scholar)
  • Gannett, Lisa, 2003a, “The Normal Genome in Twentieth-Century Evolutionary Thought,” Studies in History and Philosophy of Biological and Biomedical Sciences 34: 143–185. (Scholar)
  • Gannett, Lisa, 2003b, “Making Populations: Bounding Genes in Space and in Time,” Philosophy of Science 70: 989–1001. (Scholar)
  • Gannett, Lisa, 2005, “Group Categories in Pharmacogenetics Research,” Philosophy of Science 72: 1232–1247. (Scholar)
  • Gavaghan, Colin, 2000, “Deregulating the Genetic Supermarket: Preimplantation Screening, Future People, and the Harm Principle,” Cambridge Quarterly of Healthcare Ethics 9: 242–260. (Scholar)
  • Ghiselin, Michael T., 1974, “A Radical Solution to the Species Problem,” Systematic Zoology 23: 536–544. (Scholar)
  • Gifford, Fred, 1990, “Genetic Traits,” Biology and Philosophy 5: 327–347. (Scholar)
  • Gilbert, Walter, 1992, “A Vision of the Grail,” in The Code of Codes: Scientific and Social Issues in the Human Genome Project, edited by Daniel J. Kevles and Leroy Hood, 83–97, Cambridge, MA and London: Harvard University Press. (Scholar)
  • Godfrey-Smith, Peter, 2000, “On the Theoretical Role of ‘Genetic Coding,’” Philosophy of Science 67: 26–44. (Scholar)
  • Goering, Sara, 2000, “Gene Therapies and the Pursuit of a Better Human,” Cambridge Quarterly of Healthcare Ethics 9: 330–341. (Scholar)
  • Goffeau, A. et al., 1996, “Life with 6000 Genes,” Science 274 (25 Oct): 546–567. (Scholar)
  • Gosselin, Peter G., 2000, “Public Project's Chief: Quiet but No Pushover,” Los Angeles Times (27 Jun). (Scholar)
  • Gostin, Larry, 1991, “Genetic Discrimination: The Use of Genetically Based Diagnostic and Prognostic Tests by Employers and Insurers,” American Journal of Law and Medicine 17(1–2): 109–144. (Scholar)
  • Green, Philip, 1997, “Against a Whole-Genome Shotgun,” Genome Research 7: 410–417. (Scholar)
  • Green, Phil, 2002, “Whole-Genome Disassembly,” Proceedings of the National Academy of Sciences 99: 4143–4144. (Scholar)
  • Griesemer, James R., 1994, “Tools for Talking: Human Nature, Weismannism, and the Interpretation of Genetic Information,” in Are Genes Us? 69–88. (Scholar)
  • Griffiths, Paul E., 2001, “Genetic Information: A Metaphor in Search of a Theory,” Philosophy of Science 68: 394–412. (Scholar)
  • Griffiths, Paul E., 2006, “The Fearless Vampire Conservator: Philip Kitcher, Genetic Determinism, and the Informational Gene,” in Genes in Development: Re-reading the Molecular Paradigm, edited by Eva M. Neumann-Held and Christoph Rehmann-Sutter, 175-198, Durham, NC: Duke University Press. (Scholar)
  • Griffiths, P.E. and R.D. Gray, 1994, “Developmental Systems and Evolutionary Explanation,” Journal of Philosophy 91: 277–304. (Scholar)
  • Griffiths, Paul E. and Robin D. Knight, 1998, “What Is the Developmentalist Challenge?Philosophy of Science 65: 253–258. (Scholar)
  • Griffiths, Paul E. and Eva M. Neumann-Held, 1999, “The Many Faces of the Gene,” BioScience 49: 656–674. (Scholar)
  • Griffiths, Paul E. and Karola Stotz, 2006, “Genes in the Postgenomic Era,” Theoretical Medicine and Bioethics 27: 499–521. (Scholar)
  • Gyapay, Gabor et al., 1994, “The 1993–94 Généthon Human Genetic Linkage Map,” Nature Genetics 7: 246–339. (Scholar)
  • Habermas, Jürgen, 2003, The Future of Human Nature, Polity Press. (Scholar)
  • Hansson, Sven Ove, 2004, “The Ethics of Biobanks,” Cambridge Quarterly of Healthcare Ethics 13: 319–326. (Scholar)
  • Harris, John, 1993, “Is Gene Therapy a Form of Eugenics?Bioethics 7: 178–187. (Scholar)
  • Harris, John, 2001, “One Principle and Three Fallacies of Disability Studies,” Journal of Medical Ethics 27: 383–387. (Scholar)
  • Harris, John, and Kirsty Keywood, 2001, “Ignorance, Information and Autonomy,” Theoretical Medicine 22: 415–436. (Scholar)
  • Hattori, M., et al., 2000, “The DNA Sequence of Human Chromosome 21,” Nature 405 (18 May): 311–319. (Scholar)
  • Hedgecoe, Adam M., 2001, “Ethical Boundary Work: Geneticization, Philosophy and the Social Sciences,” Medicine, Health Care, and Philosophy 4: 305–309. (Scholar)
  • Helgesson, Gert and Linus Johnsson, 2005, “The Right to Withdraw Consent to Research on Biobank Samples,” Medicine, Health Care, and Philosophy 8: 315–321. (Scholar)
  • Hesslow, Germund, 1983, “Explaining Differences and Weighting Causes,” Theoria 49: 87–111. (Scholar)
  • Hesslow, Germund, 1984, “What is a Genetic Disease? On the Relative Importance of Causes,” in Health, Disease, and Causal Explanations in Medicine, edited by Lennart Nordefelt and B. Ingemar B. Lindahl, 183–193, Dordrecht: D. Reidel. (Scholar)
  • Holloway, Marguerite, 1995, “Turning the Inside Out,” Scientific American (June): 49–50. (Scholar)
  • Holtzman, Neil A., 1989, Proceed with Caution: Predicting Genetic Risks in the Recombinant DNA Era, Baltimore and London: Johns Hopkins University Press. (Scholar)
  • Holtzman, Neil A. and Michael S. Watson, eds., 1997, “Promoting Safe and Effective Genetic Testing in the United States,” Final Report of the Task Force on Genetics Testing [Available online]. (Scholar)
  • Hood, Leroy, 1992, “Biology and Medicine in the Twenty-First Century,” in The Code of Codes, 136–163. (Scholar)
  • Hubbard, Ruth, 1990, The Politics of Women's Biology, New Brunswick and London: Rutgers University Press. (Scholar)
  • Hubbard, Ruth, 1994, “Constructs of Genetic Difference: Race and Sex,” in Genes and Human Self-Knowledge: Historical and Philosophical Reflections on Modern Genetics, edited by Robert F. Weir, Susan C. Lawrence, and Evan Fales, Iowa City, IA: University of Iowa Press. (Scholar)
  • Hubbard, Ruth and Elijah Wald, 1993, Exploding the Gene Myth: How Genetic Information is Produced and Manipulated by Scientists, Physicians, Employers, Insurance Companies, Educators, and Law Enforcers, Boston: Beacon Press. (Scholar)
  • Hudson, Kathy L., Karen H. Rothenberg, Lori B. Andrews, Mary Jo Ellis Kahn, and Francis S. Collins, 1995, “Genetic Discrimination and Health Insurance: An Urgent Need for Reform,” Science 270 (20 Oct): 1945–1954. (Scholar)
  • Hudson, Thomas J., et al., 1995, “An STS-Based Map of the Human Genome,” Science (22 Dec): 1945–1954. (Scholar)
  • Huggins, Marlene et al., 1990, “Ethical and Legal Dilemmas Arising during Predictive Testing for Adult-Onset Disease: The Case of Huntington Disease,” American Journal of Human Genetics 47: 4–12. (Scholar)
  • HUGO Ethics Committee, 2000, “Statement on Benefit-Sharing” [Available online]. (Scholar)
  • Hull, David L., 1965, “The Effect of Essentialism on Taxonomy: Two Thousand Years of Stasis,” British Journal for the Philosophy of Science 15: 314–326; 16:1–18. (Scholar)
  • Hull, David L., 1974, Philosophy of Biological Science. NJ: Prentice-Hall. (Scholar)
  • Hull, David L., 1978, “A Matter of Individuality,” Philosophy of Science 45: 335–360. (Scholar)
  • Hull, David L., 1994, “Species, Races, and Genders: Differences Are Not Deviations,” in Genes and Human Self-Knowledge. (Scholar)
  • International Human Genome Sequencing Consortium, 2001, “Initial Sequencing and Analysis of the Human Genome,” Nature 409 (15 Feb): 860–921. (Scholar)
  • Jaroff, Leon, 1989, “The Gene Hunt,” Time (20 March). (Scholar)
  • Juengst, Eric T., 1997, “Can Enhancement Be Distinguished from Prevention in Genetic Medicine?Journal of Medicine and Philosophy 22: 125–142. (Scholar)
  • Juengst, Eric T., 1998, “Groups as Gatekeepers to Genomic Research: Conceptually Confusing, Morally Hazardous, and Practically Useless,” Kennedy Institute of Ethics Journal 8: 183–200. (Scholar)
  • Kahn, Jeffrey P. and Anna C. Mastroianni, 2004, “Creating a Stem Cell Donor: A Case Study in Reproductive Genetics,” Kennedy Institute of Ethics Journal 14: 81–96. (Scholar)
  • Kahn, Patricia, 1996, “German Genome Program: The Right Mix of Form and Function,” Science 273 (2 Aug): 570–571. (Scholar)
  • Kaiser, Jocelyn, 1997, “Canada Seeks to Revive Genome Project,” Science 277 (18 July): 303. (Scholar)
  • Kaiser, Jocelyn, 2002, “Population Databases Boom, From Iceland to the U.S.” Science 298 (8 Nov): 1158–1161. (Scholar)
  • Kaplan, Jonathan Michael, 2000, The Limits and Lies of Human Genetics Research: Dangers for Social Policy, New York: Routledge. (Scholar)
  • Kass, Leon R., 2002, Life, Liberty and the Defense of Dignity: The Challenge for Bioethics, San Francisco: Encounter Books. (Scholar)
  • Kass, Nancy E., 1997, “The Implications of Genetic Testing for Health and Life Insurance,” in Genetic Secrets, 299–316. (Scholar)
  • Kavka, Gregory S., 1994, “Upside Risks: Social Consequences of Beneficial Biotechnology,” in Are Genes Us? 155–179. (Scholar)
  • Keller, Evelyn Fox, 1992. “Nature, Nurture, and the Human Genome Project.” In Code of Codes, 281–299. (Scholar)
  • Keller, Evelyn Fox, 1994, “Master Molecules,” in Are Genes Us? 89–98. (Scholar)
  • Keller, Evelyn Fox, 1999, “Understanding Development,” Biology and Philosophy 14: 321–330. (Scholar)
  • Keller, Evelyn Fox, 2000, The Century of the Gene, Cambridge, MA and London: Harvard University Press. (Scholar)
  • Kevles, Daniel J., 1992, “Out of Eugenics: The Historical Politics of the Human Genome,” in Code of Codes, 3–36. (Scholar)
  • Kevles, Daniel J., 1994, “Eugenics and the Human Genome Project: Is the Past Prologue?” in Justice and the Human Genome Project, 14–29. (Scholar)
  • Kitcher, Philip, 1992, “Gene: Current Usages,” in Keywords in Evolutionary Biology, edited by Evelyn Fox Keller and Elisabeth A. Lloyd, 128–131, Cambridge, MA: Harvard University Press. (Scholar)
  • Kitcher, Philip, 1995, “Who's Afraid of the Human Genome Project?PSA 1994, edited by David Hull, Micky Forbes, and Richard M. Burian, 313–321, East Lansing, MI: Philosophy of Science Association. (Scholar)
  • Kitcher, Philip, 1996, The Lives to Come: The Genetic Revolution and Human Possibilities, New York: Simon & Schuster. (Scholar)
  • Kitcher, Philip, 2001. Science, Truth, and Democracy. Oxford and New York: Oxford University Press. (Scholar)
  • Knoppers, Bartha Maria, 1999, “Status, Sale and Patenting of Human Genetic Material: An International Survey,” Nature Genetics 22: 23–26. (Scholar)
  • Kohler, Robert E., 1994, Lords of the Fly: Drosophila Genetics and the Experimental Life, Chicago; University of Chicago Press. (Scholar)
  • Koshland, Daniel E. Jr., 1989, “Sequences and Consequences of the Human Genome,” Science 246 (13 Oct): 189. (Scholar)
  • Lander, Eric S., 1996, “The New Genomics: Global Views of Biology,” Science 274 (25 Oct): 536–539. (Scholar)
  • Lappé, Marc, 1991, “Ethical Issues in Manipulating the Human Germ-Line,” Journal of Medicine and Philosophy 16: 621–639. (Scholar)
  • Lappé, Marc A., 1994, “Justice and the Limitations of Genetic Knowledge,” in Justice and the Human Genome Project, 153–168. (Scholar)
  • Launis, Vaikko, 2003, “Solidarity, Genetic Discrimination, and Insurance,” Social Theory and Practice 29: 87–111. (Scholar)
  • Lee, Carol, 1993, “Creating A Genetic Underclass: The Potential for Genetic Discrimination by the Health Insurance Industry,” Pace Law Review 13: 189–228. (Scholar)
  • Lee, Thomas F., 1991, The Human Genome Project: Cracking the Genetic Code of Life, New York: Plenum Press. (Scholar)
  • Leonelli, Sabina, 2008, “Performing Abstraction: Two Ways of Modelling Arabidopsis thaliana,” Biology and Philosophy 23: 509–528. (Scholar)
  • Levy, Samuel et al., 2007, “The Diploid Genome Sequence of an Individual Human,” PLoS Biology 5: 2113–2144. (Scholar)
  • Lewontin, R. C., 1974, “The Analysis of Variance and the Analysis of Causes,” American Journal of Human Genetics 26: 400–411. (Scholar)
  • Lewontin, R.C., 1993, The Doctrine of DNA: Biology as Ideology, London: Penguin Books. (Scholar)
  • Lewontin, Richard, 2000, It Ain’t Necessarily So: The Dream of the Human Genome and Other Illusions, New York: New York Review of Books; chapter 5, “The Dream of the Human Genome,” was originally published on May 28, 1992 in The New York Review of Books. (Scholar)
  • Limoges, Camille, 1994, “Errare Humanum Est: Do Genetic Errors Have a Future?” in Are Genes Us? 113–124. (Scholar)
  • Lindsay, Ronald A., 2005, “Enhancements and Justice: Problems in Determining the Requirements of Justice in a Genetically Transformed Society,” Kennedy Institute of Ethics Journal 15: 3–38. (Scholar)
  • Lippman, Abby. 1991. “Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities.” American Journal of Law and Medicine 42: 15–50. (Scholar)
  • Litt, M. and J.A. Luty, 1989, “A Hypervariable Microsatellite Revealed by In Vitro Amplification of a Dinucleotide Repeat Within the Cardiac Muscle Actin Gene,” American Journal of Human Genetics 44(3): 397–401. (Scholar)
  • Lloyd, Elisabeth A., 1994, “Normality and Variation: The Human Genome Project and the Ideal Human Type,” in Are Genes Us? 99–112. (Scholar)
  • Loftis, J. Robert, 2005, “Germ-line Enhancement of Humans and Nonhumans,” Kennedy Institute of Ethics Journal 15: 57–76. (Scholar)
  • MacDonald, Chris and Bryn Williams-Jones, 2002, “Ethics and Genetics: Susceptibility Testing in the Workplace,” Journal of Business Ethics 35: 235–241. (Scholar)
  • Marshall, Eliot, 1996a, “NIH Launches the Final Push to Sequence the Genome,” Science 272 (12 Apr): 188–189. (Scholar)
  • Marshall, Eliot, 1996b, “Whose Genome Is It, Anyway?” Science 273 (27 Sept): 1788–1789. (Scholar)
  • Marshall, Eliot, 1996c, “The Genome Project's Conscience,” Science 274 (25 Oct): 488–490. (Scholar)
  • Mauron, Alex and Jean-Marie Thevoz, 1991, “Germ-line Engineering: A Few European Voices,” Journal of Medicine and Philosophy 16: 649–666. (Scholar)
  • McEwen, Jean E., 1997, “DNA Data Banks,” in Genetic Secrets, 231–251. (Scholar)
  • McEwen, Jean E. and Philip R. Reilly, 1994, “Stored Guthrie Cards as DNA ‘Banks,’” American Journal of Human Genetics 55: 196–200. (Scholar)
  • McKie, Robin, 2002, “I’m the Human Genome, says ‘Darth Venter’ of Genetics,” Observer (28 Apr).
  • McKusick, Victor A., 1989, “Mapping and Sequencing the Human Genome,” The New England Journal of Medicine 320 (6 Apr): 910–915. (Scholar)
  • Mehlman, Maxwell J., 2003, Wondergenes: Genetic Enhancement and the Future of Society, Bloomington: Indiana University Press. (Scholar)
  • Mehlman, Maxwell J. and Jeffrey R. Botkin, 1998, Access to the Genome: The Challenge to Equality, Washington, DC: Georgetown University Press. (Scholar)
  • Merz, Jon F., Antigone G. Kriss, Debra G.B. Leonard, and Mildred K. Cho, 2002, “Diagnostic Testing Fails the Test,” Nature 415 (7 Feb): 577–579. (Scholar)
  • Meyer, Roberta A., 2004, “The Insurer Perspective,” in Genetics and Life Insurance, 27–47. (Scholar)
  • Moore, Adam D., 2000, “Owning Genetic Information and Gene Enhancement Techniques: Why Privacy and Property Rights May Undermine Social Control of the Human Genome,” Bioethics 14: 97–119. (Scholar)
  • Moseley, Ray, 1991, “Commentary: Maintaining the (Somatic/Germ-line) Distinction: Some Ethical Drawbacks,” Journal of Medicine and Philosophy 16: 641–647. (Scholar)
  • Moss, Lenny, 2003, What Genes Can’t Do, Cambridge, MA and London: MIT Press. (Scholar)
  • Munson, Ronald and Lawrence H. Davis, 1992, “Germ-Line Genetic Therapy and the Medical Imperative,” Kennedy Institute of Ethics Journal 2: 137–158. (Scholar)
  • Murphy, Timothy F., 1994, “The Genome Project and the Meaning of Difference,” in Justice and the Human Genome Project, 1–13. (Scholar)
  • Murray, Thomas H., 1997, “Genetic Exceptionalism and ‘Future Diaries’: Is Genetic Information Different from Other Medical Information?” in Genetic Secrets, 60–73. (Scholar)
  • Myers, Eugene M., Granger G. Sutton, Hamilton O. Smith, Mark D. Adams, and J. Craig Venter, 2002, “On the Sequencing and Assembly of the Human Genome,” Proceedings of the National Academy of Sciences 99: 4145–4146. (Scholar)
  • National Human Genome Research Institute, 2003, “International Consortium Completes Human Genome Project” (14 April); [Available online]. (Scholar)
  • National Institutes of Health Workshop on Population Screening for the Cystic Fibrosis Gene, 1990, “Special Report: Statement from the National Institutes of Health Workshop on Population Screening for the Cystic Fibrosis Gene,” New England Journal of Medicine 323: 70. (Scholar)
  • National Research Council Committee on Mapping and Sequencing the Human Genome, 1988, Mapping and Sequencing the Human Genome, Washington, D.C.: National Academy Press. (Scholar)
  • Nelkin, Dorothy, 1992, “The Social Power of Genetic Information,” in Code of Codes, pp. 177–190. (Scholar)
  • Nelkin, Dorothy, 2002, “Patenting Genes and the Public Interest,” American Journal of Bioethics 2(3): 13–15. (Scholar)
  • Nelkin, Dorothy and M. Susan Lindee, 1995, The DNA Mystique: The Gene as a Cultural Icon, New York: W.H Freeman. (Scholar)
  • Nelkin, Dorothy and Laurence Tancredi, 1989, Dangerous Diagnostics: The Social Power of Biological Information, New York: Basic Books. (Scholar)
  • Neumann-Held, Eva M., 1999, “The Gene is Dead—Long Live the Gene: Conceptualizing Genes the Constructionist Way,” in Sociobiology and Bioeconomics: The Theory of Evolution in Biological and Economic Theory, edited by P. Koslowski, 105–137. Berlin: Springer-Verlag. (Scholar)
  • Nolan, Kathleen, 1991, “Commentary: How Do We Think about the Ethics of Human Germ-line Genetic Therapy?Journal of Medicine and Philosophy 16: 613–619. (Scholar)
  • Normile, Dennis and Elizabeth Pennisi, 2002, “Rice: Boiled Down to Bare Essentials,” Science 296 (5 Apr): 32–36. (Scholar)
  • Nozick, Robert, 1974, Anarchy, State, and Utopia, New York: Basic Books. (Scholar)
  • Office of Technology Assessment, 1988, Mapping Our Genes: Genome Projects: How Big, How Fast? Baltimore and London: Johns Hopkins University Press. (Scholar)
  • O’Neill, Onora, 2001, “Informed Consent and Genetic Information,” Studies in History and Philosophy of Biological and Biomedical Sciences 32(4): 689–704. (Scholar)
  • Orentlicher, David, 1997, “Genetic Privacy in the Patient-Physician Relationship,” in Genetic Secrets, 77–91. (Scholar)
  • Oyama, Susan, 1985, The Ontogeny of Information: Developmental Systems and Evolution, Cambridge: Cambridge University Press. (Scholar)
  • Oyama, Susan, Paul E. Griffiths, and Russell Gray, editors, 2001, Cycles of Contingency: Developmental Systems and Evolution, Cambridge, MA: MIT Press. (Scholar)
  • Parens, Erik, 1995, “The Goodness of Fragility: On the Prospect of Genetic Technologies Aimed at the Enhancement of Capacities,” Kennedy Institute of Ethics Journal 5: 141–153. (Scholar)
  • Parens, Erik, 2004, “Genetic Differences and Human Identities,” Hastings Center Report 34 (1): S4-S35. (Scholar)
  • Parens, Erik and Adrienne Asch, 1999, “The Disability Rights Critique of Prenatal Genetic Testing: Reflections and Recommendations,” Special Supplement, Hastings Center Report 29 (5): S1-S22. (Scholar)
  • Parthasarathy, Shobita, 2004, “Regulating Risk: Defining Genetic Privacy in the United States and Britain,” Science, Technology, & Human Values 29: 332–352. (Scholar)
  • Paul, Diane B., 1994a, “Is Human Genetics Disguised Eugenics?” in Genes and Human Self-Knowledge, 67-83. (Scholar)
  • Paul, Diane B., 1994b, “Eugenic Anxieties, Social Realities, and Political Choices,” in Are Genes Us? 142–154. (Scholar)
  • Paul, Diane B., 1995, “Toward a Realistic Assessment of PKU Screening,” PSA 1994, edited by David Hull, Micky Forbes, and Richard M. Burian, 322–328, East Lansing, MI: Philosophy of Science Association. (Scholar)
  • Paul, Diane B., 2000, “Commentary on ‘Utopian Eugenics,’” in Controlling Our Destinies: Historical, Philosophical, Ethical, and Theological Perspectives on the Human Genome Project, edited by Phillip R. Sloan, 263–268, Notre Dame, IN: University of Notre Dame Press. (Scholar)
  • Pennisi, Elizabeth, 1999, “Academic Sequencers Challenge Celera in a Sprint to the Finish,” Science (18 Mar): 1822–1823. (Scholar)
  • Pennisi, Elizabeth, 2000, “Finally, the Book of Life and Instructions for Navigating It,” Science 288 (30 Jun): 2304–2307. (Scholar)
  • Pennisi, Elizabeth, 2003, “A Low Number Wins the GeneSweep Pool,” 300 (6 Jun): 1484. (Scholar)
  • Peters, Ted, 1995, “‘Playing God’ and Germ-line Intervention,” Journal of Medicine and Philosophy 20: 365–386. (Scholar)
  • Pokorski, Robert J., 1994, “Use of Genetic Information by Private Insurers,” in Justice and the Human Genome Project, 91–109. (Scholar)
  • Proctor, Robert N., 1992, “Genomics and Eugenics: How Fair Is the Comparison?” in Gene Mapping: Using Law and Ethics as Guides, edited by George J. Annas and Sherman Elias, 57–93, New York and Oxford: Oxford University Press. (Scholar)
  • Quaid, Kimberley A., 1994, “A Few Words from a ‘Wise’ Woman,” in Genes and Human Self-Knowledge, 3-17. (Scholar)
  • Rader, Karen, 2004, Making Mice: Standardizing Animals for American Biomedical Research, 1900–1955, Princeton: Princeton University Press. (Scholar)
  • Radick, Gregory, 2001, “A Critique of Kitcher on Eugenic Reasoning,” Studies in History and Philosophy of Biological and Biomedical Sciences 32: 741–751. (Scholar)
  • Rasko, John E.J., Gabrielle M. O'sullivan, and Rachel A. Ankeny, 2006, “Is Inheritable Genetic Modification the New Dividing Line?” in Ethics of Inheritable Genetic Modification, 1–15. (Scholar)
  • Reardon, Jenny, 2004, Race to the Finish: Identity and Governance in an Age of Genomics, Princeton: Princeton University Press. (Scholar)
  • Reed, Esther D., 2006, “Property Rights, Genes, and Common Good,” Journal of Religious Ethics 34: 41–67. (Scholar)
  • Resnik, David B., 1997a, “The Morality of Human Gene Patents,” Kennedy Institute of Ethics Journal 7: 43–61. (Scholar)
  • Resnik, David B., 1997b, “Genetic Engineering and Social Justice: A Rawlsian Approach,” Social Theory and Practice 23: 427–448. (Scholar)
  • Resnik, David B., 2000, “The Moral Significance of the Therapy-Enhancement Distinction in Human Genetics,” Cambridge Quarterly of Healthcare Ethics 9: 365–377. (Scholar)
  • Resnik, David B., 2004, Owning the Genome: A Moral Analysis of DNA Patenting, Albany: State University of New York Press. (Scholar)
  • Reynolds, Tom, 2000, “Gene Patent Race Speeds Ahead Amid Controversy, Concern,” Journal of the National Cancer Institute, 92(3): 184–186. (Scholar)
  • Rheinberger, Hans-Jörg, 2000, “Gene Concepts: Fragments from the Perspective of Molecular Biology,” in The Concept of the Gene in Development and Evolution: Historical and Epistemological Perspectives, edited by Peter J. Beurton, Raphael Falk, and Hans-Jörg Rheinberger, 219-239, Cambridge: Cambridge University Press. (Scholar)
  • Richards, Martin, 2001, “How Distinctive Is Genetic Information?Studies in History and Philosophy of Biological and Biomedical Sciences 32: 663–687. (Scholar)
  • Ridley, R.M., C.D. Frith, L.A. Farrer, and P.M. Conneally, 1991, “Patterns of Inheritance of the Symptoms of Huntington's Disease Suggestive of an Effect of Genomic Imprinting,” Journal of Medical Genetics 28: 224–231. (Scholar)
  • Rhodes, Rosamond, 1998, “Genetic Links, Family Ties, and Social Bonds: Rights and Responsibilities in the Face of Genetic Knowledge,” Journal of Medicine and Philosophy 23: 10–30. (Scholar)
  • Rhodes, Rosamond, 2000, “Autonomy, Respect, and Genetic Information Policy: A Reply to Tuija Takala and Matti Häyry,” Journal of Medicine and Philosophy 25: 114–120. (Scholar)
  • Robert, Jason Scott, 2004, Embryology, Epigenesis, and Evolution, Cambridge: Cambridge University Press. (Scholar)
  • Robert, Jason Scott and Françoise Baylis, 2003, “Crossing Species Boundaries,” American Journal of Bioethics 3(3): 1–13. (Scholar)
  • Root, Michael, 2003, “The Use of Race in Medicine as a Proxy for Genetic Differences,” Philosophy of Science 70: 1173–1183. (Scholar)
  • Rose, Steven, R.C. Lewontin, and Leon J. Kamin, 1984, Not in Our Genes: Biology, Ideology and Human Nature, London: Penguin Books. (Scholar)
  • Rosenberg, Alex, 1995, “Subversive Reflections on the Human Genome Project,” PSA 1994, edited by David Hull, Micky Forbes, and Richard M. Burian, 329–335, East Lansing, MI: Philosophy of Science Association. (Scholar)
  • Rosenberg, Alex, 1997, “Reductionism Redux: Computing the Embryo,” Biology and Philosophy 12: 445–470. (Scholar)
  • Rosoff, Philip M. and Alex Rosenberg, 2006, “How Darwinian Reductionism Refutes Genetic Determinism,” Studies in History and Philosophy of Biological and Biomedical Sciences 37: 122–135. (Scholar)
  • Rothenberg, Karen et al., 1997, “Genetic Information and the Workplace: Legislative Approaches and Policy Challenges,” Science 275 (21 Mar): 1755–1757. (Scholar)
  • Rothstein, Mark A., 1997, “The Law of Medical and Genetic Privacy in the Workplace,” in Genetic Secrets, 281–298. (Scholar)
  • Rothstein, Mark A., 2005, “Genetic Exceptionalism and Legislative Pragmatism,” Hastings Center Report 35(4): 27–33. (Scholar)
  • Sagoff, Marc, 2002, “Intellectual Property and Products of Nature,” American Journal of Bioethics 2(3): 12–13. (Scholar)
  • Salopek, Paul, 1997, “Genes Offer Sampling of Hope and Fear,” Chicago Tribune (28 Apr). (Scholar)
  • Sarkar, Sahotra, 1996, “Biological Information: A Sceptical Look at Some Central Dogmas of Molecular Biology,” in The Philosophy and History of Molecular Biology: New Perspectives, edited by Sahotra Sarkar, 187–232, Dordrecht: Kluwer. (Scholar)
  • Sarkar, Sahotra, 1998, Genetics and Reductionism, Cambridge: Cambridge University Press. (Scholar)
  • Sarkar, Sahotra and Alfred I. Tauber, 1991, “Fallacious Claims for the HGP,” Nature 353 (24 Oct): 691. (Scholar)
  • Savulescu, Julian, 2001, “Procreative Beneficence: Why We Should Select the Best Children,” Bioethics 15: 413–426. (Scholar)
  • Schaffner, Kenneth F., 1998a, “Model Organisms and Behavioral Genetics: A Rejoinder,” Philosophy of Science 65: 276–288. (Scholar)
  • Schaffner, Kenneth F., 1998b, “Genes, Behavior, and Developmental Emergentism: One Process, Indivisible?Philosophy of Science 65: 209–252. (Scholar)
  • Schonfeld, Toby, 2003, “Parents of Unhappy Poets: Fiduciary Responsibility and Genetic Enhancements,” Cambridge Quarterly of Healthcare Ethics 12: 411–417. (Scholar)
  • Scully, Jackie Leach, 2001, “Drawing a Line: Situating Moral Boundaries in Genetic Medicine,” Bioethics 15: 189–204. (Scholar)
  • Sevick, Mary Ann, Donna G. Nativio, and Terrance McConnell, 2005, “Genetic Testing of Children for Late Onset Disease,” Cambridge Quarterly of Healthcare Ethics 14: 47–56. (Scholar)
  • Shiva, Vandana, 1996, Biopiracy: The Plunder of Nature and Knowledge, Boston: South End Press. (Scholar)
  • Shickle, Darren, 2006, “The Consent Problem within DNA Biobanks,” Studies in History and Philosophy of Biological and Biomedical Sciences 37: 503–519. (Scholar)
  • Shizuya, Hiroaki, Bruce Birren, Ung-Jin Kim, Valeria Mancino, Tatiana Slepak, Yoshiaki Tachiiri, and Melvin Simon, 1992, “Cloning and Stable Maintenance of 300-Kilobase-Pair Fragments of Human DNA in Escherichia coli Using an F-Factor-Based Vector,” Proceedings of the National Academy of Sciences 89: 8794–8797. (Scholar)
  • Singer, George H.S., 1996, “Clarifying the Duties and Goals of Genetic Counselors: Implications for Nondirectiveness,” in Morality and the New Genetics: A Guide for Students and Health Care Providers, edited by Bernard Gert, Edward M. Berger, George F. Cahill, Jr., K. Danner Clouoser, Charles M. Culver, John B. Moeschler, and George H. S. Singer, 125–145, Sudbury, MA: Jones and Bartlett Publishers. (Scholar)
  • Smaglik, Paul, 2000, “Could AIDS Treatments Slip through Patents Loophole?” Nature 404 (23 Mar): 322. (Scholar)
  • Smith, Kelly C., 1992, “The New Problem of Genetics: A Response to Gifford,” Biology and Philosophy 7: 331–348. (Scholar)
  • Smith, Kelly C., 2001, “A Disease by Any Other Name: Musings on the Concept of a Genetic Disease,” Medicine, Health Care and Philosophy 4: 19–30. (Scholar)
  • Sober, Elliott, 2001, “Separating Nature and Nurture,” in Genetics and Criminal Behavior, pp. 47–78. (Scholar)
  • Stock, Gregory, 2003, Redesigning Humans: Choosing Our Genes, Changing Our Futures, Boston and New York: Houghton Mifflin. (Scholar)
  • Stotz, Karola, Paul E. Griffiths, and Rob Knight, 2004, “How Biologists Conceptualize Genes: An Empirical Study,” Studies in the History and Philosophy of Biological and Biomedical Sciences 35: 647–673. (Scholar)
  • Swinbanks, David, 1991, “Japan's Human Genome Project Takes Shape,” Nature 351 (20 Jun): 593. (Scholar)
  • Swinbanks, David, 1994, “Institute to Boost Japan Sequencing Efforts,” Nature 372 (3 Nov): 6. (Scholar)
  • Swinbanks, David, 1995, “MITI Drops Headlights for Gene Sequencing,” Nature 374 (13 Apr): 583. (Scholar)
  • Takala, Tuija, 1999, “The Right to Genetic Ignorance Confirmed,” Bioethics 13: 288–293. (Scholar)
  • Takala, Tuija and Matti Häyry, 2000, “Genetic Ignorance, Moral Obligations and Social Duties,” Journal of Medicine and Philosophy 25: 107–113. (Scholar)
  • Tauber, Alfred I. and Sahotra Sarkar, 1992, “The Human Genome Project: Has Blind Reductionism Gone Too Far?Perspectives in Biology and Medicine 35: 220–235. (Scholar)
  • Tautz, Diethard, 1989, “Hypervariability of Simple Sequences as a General Source for Polymorphic DNA Markers,” Nucleic Acids Research 17: 6463–6471. (Scholar)
  • ten Have, Henk A.M.J., 2001, “Genetics and Culture: The Geneticization Thesis,” Medicine, Health Care, and Philosophy 4: 295–304. (Scholar)
  • Thompson, Larry, 1989, “The Price of Knowledge: Genetic Tests That Predict Dire Conditions Become a Two-Edged Sword,” Washington Post (10 Oct): F7. (Scholar)
  • United States Department of Commerce Patent and Trademark Office, 2001, “Utility Examination Guidelines,” Federal Register 66(4): 1092–1099. (Scholar)
  • van der Weele, Cor, 1999, Images of Development: Environmental Causes in Ontogeny, Albany: State University of New York Press. (Scholar)
  • Vehmas, Simo, 2001, “Just Ignore It? Parents and Genetic Information,” Theoretical Medicine 22: 473–484. (Scholar)
  • Venter, J. Craig, Hamilton O. Smith, and Leroy Hood, 1996, “A New Strategy for Genome Sequencing,” Nature 381 (30 May): 364–366. (Scholar)
  • Venter, J. Craig, 2001, “The Sequence of the Human Genome,” Science 291 (16 Feb): 1304–1351. (Scholar)
  • Vicedo, Marga, 1992, “The Human Genome Project: Towards an Analysis of the Empirical, Ethical, and Conceptual Issues Involved,” Biology and Philosophy 7: 255–278. (Scholar)
  • Wade, Nicholas, 2003, “Once Again, Scientists Say Human Genome is Complete,” New York Times (15 April): F1; LexisNexis Academic. (Scholar)
  • Wadman, Meredith, 1999, “Human Genome Project Aims to Finish ‘Working Draft’ Next Year,” Nature 398 (18 Mar): 177. (Scholar)
  • Wahlsten, Douglas, 1990, “Insensitivity of the Analysis of Variance to Heredity-Environment Interaction,” Behavioral and Brain Sciences 13: 109–161. (Scholar)
  • Wasserman, David, 2001, “Genetic Predispositions to Violent and Antisocial Behavior: Responsibility, Character, and Identity,” in Genetics and Criminal Behavior, 303–327. (Scholar)
  • Waters, C. Kenneth, 1994, “Genes Made Molecular,” Philosophy of Science 61: 163–185. (Scholar)
  • Waterston, Robert H., Eric S. Lander, and John E. Sulston, 2002, “On the Sequencing of the Human Genome,” Proceedings of the National Academy of Sciences 99: 3712–3716. (Scholar)
  • Watson, James D. 1990. “The Human Genome Project: Past, Present, and Future.” Science 248 (6 Apr): 44–49. (Scholar)
  • Watson, James D., 1992, “A Personal View of the Project,” in Code of Codes, pp. 164–173. (Scholar)
  • Watson, James D., 2003, “A Molecular Genetics Perspective,” in Behavioral Genetics in the Postgenomic Era, edited by Robert Plomin, John C. DeFries, Ian W. Craig, and Peter McGuffin, xxi-xxii. Washington, DC: American Psychological Association. (Scholar)
  • Watson, James D. with Andrew Berry, 2003, DNA: The Secret of Life, New York: Alfred A. Kopf. (Scholar)
  • Weber, J.L. and P.E. May, 1989, “Abundant Class of Human DNA Polymorphisms which Can Be Typed Using the Polymerase Chain Reaction,” American Journal of Human Genetics 44: 388–396. (Scholar)
  • Weber, James L. and Eugene W. Myers, 1997, “Human Whole-Genome Shotgun Sequencing,” Genome Research 7: 401–409. (Scholar)
  • Weiner, Jonathan, 1999, Time, Love, Memory: A Great Biologist and His Quest for the Origins of Behavior, New York: Knopf. (Scholar)
  • Wenz, Peter, 2005, “Engineering Genetic Injustice,” Bioethics 19: 1–11. (Scholar)
  • Wertz, Dorothy C., 2002, “Genetic Discrimination—An Overblown Fear?” Nature Reviews, Genetics 3: 496. (Scholar)
  • Wheeler, David A. et al., 2008, “The Complete Genome of an Individual by Massively Parallel DNA Sequencing,” Nature 452 (17 April): 872–876. (Scholar)
  • White House, 2000, “White House Remarks on Decoding of Genome” (transcript), New York Times (27 June). (Scholar)
  • Wimsatt, William C., 1998, “Simple Systems and Phylogenetic Diversity,” Philosophy of Science 65: 267–275. (Scholar)
  • World Federation of Neurology Research Group on Huntington's Disease, 1993, “Presymptomatic Testing for Huntington's Disease: A World Wide Survey,” Journal of Medical Genetics 30: 1020–1022. (Scholar)
  • Wolpert, Lewis, 1994, “Do We Understand Development?” Science 266 (28 Oct): 571–572. (Scholar)
  • Wulff, Henrik R., 1984, “Comments on Hesslow's ‘What is a Genetic Disease?’” in Health, Disease, and Causal Explanations in Medicine, 195–197. (Scholar)
  • Zick, Cathleen D., Ken R. Smith, Robert N. Mayer, and Jeffrey R. Botkin, 2000, “Genetic Testing, Adverse Selection, and the Demand for Life Insurance,” American Journal of Medical Genetics 93: 29–39. (Scholar)
  • Zimmerman, Burke K., 1991, “Human Germ-line Therapy: The Case for its Development and Use,” Journal of Medicine and Philosophy 16: 593–612. (Scholar)
  • Zohar, Noam J., 1991, “Prospects for ‘Genetic Therapy’: Can a Person Benefit from Being Altered?” Bioethics 5: 275–288. (Scholar)

Generated Mon Dec 17 08:51:44 2018